Condition
Retinal Neoplasm
Total Trials
2
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
18 treatments under study, led by Periocular Carboplatin
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
50%
1 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
2Total
Phase 2 (1)
Phase 3 (1)
Trial Status
Active Not Recruiting1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Periocular Carboplatin1
- External Beam Radiation1
- Focal Therapies1
- Vincristine And Topotecan1
- Enucleation1
Active Sponsors
- Institut Curie1
- Fondation Rothschild Paris1
- St. Jude Children's Research Hospital1
- National Cancer Institute (NCI)1
Top Investigators
Lille (FR), Oscar Lambret Center
Rouen (FR), University College Hospital
Marseille (FR), La Timone Children Hospital
Poitiers (FR), University College Hospital
Montpellier (FR), Arnaud de Villeneuve Hospital
Related Conditions
- Retinoblastoma2
- Children1